Ubs Group Ag Mei Pharma, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$0.21 - $0.35 $17,832 - $29,720
-84,915 Reduced 64.0%
47,769 $10,000
Q4 2022

Feb 08, 2023
BUY
$0.22 - $8.4 $15,610 - $596,055
70,959 Added 114.96%
132,684 $31,000
Q3 2022

Nov 10, 2022
BUY
$0.41 - $8.8 $25,170 - $540,240
61,391 Added 18380.54%
61,725 $24,000
Q2 2022

Aug 10, 2022
SELL
$0.42 - $0.65 $2,730 - $4,225
-6,500 Reduced 95.11%
334 $0
Q1 2022

May 16, 2022
SELL
$0.54 - $2.74 $17,551 - $89,058
-32,503 Reduced 82.63%
6,834 $4,000
Q4 2021

Feb 14, 2022
BUY
$2.33 - $3.37 $90,527 - $130,934
38,853 Added 8027.48%
39,337 $106,000
Q3 2021

Nov 15, 2021
SELL
$2.52 - $2.99 $8,127 - $9,642
-3,225 Reduced 86.95%
484 $1,000
Q2 2021

Aug 13, 2021
SELL
$2.6 - $3.65 $47,096 - $66,116
-18,114 Reduced 83.0%
3,709 $11,000
Q1 2021

May 12, 2021
SELL
$2.73 - $4.5 $47,059 - $77,571
-17,238 Reduced 44.13%
21,823 $75,000
Q4 2020

Feb 11, 2021
BUY
$2.6 - $3.32 $100,066 - $127,776
38,487 Added 6705.05%
39,061 $103,000
Q3 2020

Nov 12, 2020
SELL
$2.46 - $4.27 $83,994 - $145,794
-34,144 Reduced 98.35%
574 $2,000
Q2 2020

Jul 31, 2020
SELL
$1.45 - $4.3 $36,255 - $107,517
-25,004 Reduced 41.87%
34,718 $143,000
Q1 2020

May 01, 2020
SELL
$0.75 - $2.55 $27,486 - $93,452
-36,648 Reduced 38.03%
59,722 $96,000
Q4 2019

Feb 14, 2020
BUY
$1.65 - $2.48 $60,213 - $90,502
36,493 Added 60.95%
96,370 $239,000
Q3 2019

Nov 14, 2019
BUY
$1.48 - $2.52 $69,286 - $117,973
46,815 Added 358.41%
59,877 $100,000
Q2 2019

Aug 14, 2019
BUY
$2.45 - $3.32 $14,567 - $19,740
5,946 Added 83.56%
13,062 $33,000
Q1 2019

May 14, 2019
BUY
$2.52 - $3.24 $15,392 - $19,789
6,108 Added 605.95%
7,116 $21,000
Q4 2018

Feb 14, 2019
SELL
$1.92 - $4.1 $1,509 - $3,222
-786 Reduced 43.81%
1,008 $3,000
Q3 2018

Nov 14, 2018
BUY
$3.39 - $4.61 $1,637 - $2,226
483 Added 36.84%
1,794 $7,000
Q2 2018

Aug 14, 2018
BUY
$1.89 - $4.95 $572 - $1,499
303 Added 30.06%
1,311 $5,000
Q1 2018

May 15, 2018
SELL
$2.06 - $2.38 $1,532 - $1,770
-744 Reduced 42.47%
1,008 $2,000
Q4 2017

Feb 14, 2018
SELL
$1.91 - $2.83 $6,717 - $9,953
-3,517 Reduced 66.75%
1,752 $4,000
Q3 2017

Nov 14, 2017
BUY
$2.44 - $2.91 $10,396 - $12,399
4,261 Added 422.72%
5,269 $14,000
Q2 2017

Aug 14, 2017
SELL
N/A
-1,437 Reduced 58.77%
1,008 $2,000
Q1 2017

Nov 14, 2017
BUY
N/A
2,445
2,445 $4,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0
View Full List

About MEI Pharma, Inc.

MEIP Quotes by TradingView
  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $385M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email